Mammalian target of rapamycin (mTOR) is the serine/threonine protein kinase which regulates cell growth, proliferation, survival, and motility. MTOR kinase inhibitors slow down or stop the groth of mTor.
Regular Websites
The company site for Afinitor tablets outlines data about the product including its use for treatment of advanced renal cell carcinoma, press releases, and a video about the agent, as well as information about how to go about getting reimbursement and assistance. - Afinitor
http://www.afinitor.com/index.jsp
Afinitor Approved As First Treatment For Patients With Advanced Kidney Cancer
Medical News Today article from March 2009 which announces the approval of the US Food and Drug Administration's approval of Afinitor for treatment of advanced kidney cancer, details about the clinical trials, and about renal cell carcinoma. - Afinitor Approved As First Treatment For Patients With Advanced Kidney Cancer
http://www.medicalnewstoday.com/articles/144359.php
Novartis’s Afinitor Pill May Be ‘Mega-Blockbuster’
Bloomberg article delves into Afinitor and its effects on renal cell carcinoma as well as possibilities of successful treatment of lymphoma, lung, breast, and gastric cancers. - Novartis’s Afinitor Pill May Be ‘Mega-Blockbuster’
http://www.bloomberg.com/apps/news?pid=20601085&sid=aTZcqX.wysVQ